DC Chemicals

All products / DC9029

Abacavir
CAT. NO. DC9029

Abacavir

Pack sizes and prices

Pack sizePrice
1 g$300 USDRequest a quote →

In stock. Contact our team for lead time, shipping and final quotation.

Product overview

Abacavir is a powerful nucleoside analog reverse transcriptase inhibitor (NRTI) used to treat HIV and AIDS.Abacavir is a nucleoside reverse transcriptase inhibitor marketed since 1999 for the treatment of infection with the human immunodeficiency virus type 1 (HIV). Despite its clinical efficacy, abacavir administration has been associated with serious and sometimes fatal toxic events. Abacavir has been reported to undergo bioactivation in vitro, yielding reactive species that bind covalently to human serum albumin, but the haptenation mechanism and its significance to the toxic events induced by this anti-HIV drug have yet to be elucidated. The mechanism underlying abacavir hypersensitivity syndrome is related to the change in the HLA-B*5701 protein product. Abacavir binds with high specificity to the HLA-B*5701 protein, changing the shape and chemistry of the antigen-binding cleft. This results in a change in immunological tolerance and the subsequent activation of abacavir-specific cytotoxic T cells, which produce a systemic reaction known as abacavir hypersensitivity syndrome.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC9029
Product nameAbacavir
CAS136470-78-5
Molecular formulaC14H18N6O
Molecular weight286.34
Purity>98%
SMILESOC[C@@H]1C=C[C@H](N2C=NC3=C(N=C(N=C23)N)NC2CC2)C1

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — Abacavir (DC9029)

Related research products